CD8A and neoplasm: In the high-risk group, the cancer immune cycle exhibited greater dynamism, highlighted by elevated activities like the release of antigens from tumor cells and the augmented recruitment of basophils, CD8 T cells, neutrophils, and natural killer (NK) cells (Figure 8B).